SNDX241220C25000
- 0.05
- 0.000.00%
Syndax Pharmaceuticals Newsroom
Scotiabank Maintains Syndax Pharmaceuticals(SNDX.US) With Hold Rating, Cuts Target Price to $16
Syndax Pharmaceuticals Is Maintained at Sector Perform by Scotiabank
Syndax Pharmaceuticals Analyst Ratings
Express News | Syndax Pharmaceuticals Inc : Scotiabank Cuts Target Price to $16 From $18
Syndax Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Jefferies Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $43
BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $25
Express News | Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals Restructures Leadership Team
Express News | Syndax Pharmaceuticals Inc - Eliminates Chief Medical Officer Position
Barclays Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $33
Barclays Gives a Buy Rating to Syndax Pharmaceuticals (SNDX)
Trending Stocks Today | Micron Technology Falls 14.29% Post-Market
J.P. Morgan Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Raises Target Price to $39
J.P. Morgan Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX)
Express News | Syndax Pharmaceuticals Inc : JP Morgan Raises Target Price to $39 From $38
Trending Stocks Today | U-BX Technology Surges 55.86% Post-Market
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $42 to $51
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $25 to $51